Virtual Kidney Check and Follow-up

Summary

The goal of this clinical trial is to determine the most effective way to complete population-based screening for chronic kidney disease (CKD) in First Nations adults in Manitoba. The main questions it aims to answer are:

* To identify chronic kidney disease in First Nations adults in Manitoba
* To risk stratify patients as low, moderate and high risk of kidney failure and organize active surveillance by risk category
* To initiate treatments to prevent to progression of chronic kidney disease in individuals at risk of kidney failure

Participants will be randomized to:

1. Patient contact via mail with a letter and laboratory requisition for serum creatinine and urine Albumin Creatinine Ratio
2. Patient and primary care network contact via mail with a letter but no laboratory requisition

The primary outcome is the difference between groups in the proportion of individuals who undergo screening for chronic kidney disease within 6 months.

Conditions

• Kidney Disease, Chronic

Interventions

OTHER

population-based screening for chronic kidney disease

Randomized controlled trial that uses an integrated health platform for eligibility and outcome assessments

Sponsors & Collaborators

• Boehringer Ingelheim

  collaborator INDUSTRY

• Research Manitoba

  collaborator OTHER

• Manitoba Health, Seniors and Long-Term Care, Province of Manitoba

  collaborator UNKNOWN

• First Nations Health and Social Secretariat of Manitoba

  collaborator UNKNOWN

• Shared Health Manitoba

  collaborator UNKNOWN

• Seven Oaks General Hospital

  collaborator UNKNOWN

• University of Manitoba

  lead OTHER

Principal Investigators

• David Collister, MD, PhD, FRCPC · University of Manitoba

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-11-01

Primary Completion

2029-04-30

Completion

2029-04-30

Countries

• Canada

Study Locations